Evidence map›Paper›PMID 29866865›Full record

ArticleAntimicrobial agents and chemotherapy2018

Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria.

Sara Ceballos, Choon Kim, Derong Ding, Shahriar Mobashery, Mayland Chang, Carmen Torres

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research.Angewandte Chemie (International ed. in English) · 2025
    Review
  2. Article
  3. Review
  4. Unconventional Antibacterials and Adjuvants.Accounts of chemical research · 2021
    Article
  5. Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  6. Constructing and deconstructing the bacterial cell wall.Protein science : a publication of the Protein Society · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Sara CeballosArea of Biochemistry and Molecular Biology, University of La Rioja, Logroño, Spain.
Choon KimDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.
Derong DingDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.
Shahriar MobasheryDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.
Mayland ChangDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA mchang@nd.edu carmen.torres@unirioja.es.
Carmen TorresArea of Biochemistry and Molecular Biology, University of La Rioja, Logroño, Spain mchang@nd.edu carmen.torres@unirioja.es.
University of Notre Dame · USUniversidad de La Rioja · ES

Funding

Novel oxadiazols for the treatment of drug-resistant gram-positive bacteriaR01AI090818 · NIAID · UNIVERSITY OF NOTRE DAME · PI CHANG, MAYLAND F, MOBASHERY, SHAHRIAR · 2010 to 2014
$5.0M
NIAID NIH HHS R01 AI090818
6 · The paper itself

Abstract

The activities of four oxadiazoles were investigated with 210 methicillin-resistant

Indexed as

Anti-Bacterial AgentsCeftarolineCephalosporinsMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsOxacillinOxadiazolesStaphylococcus epidermidisStaphylococcus haemolyticusStaphylococcus saprophyticusStructure-Activity RelationshipVancomycin-Resistant EnterococciAnti-Bacterial AgentsCeftarolineCephalosporinsOxacillinOxadiazolesEnterococcusMICMRSAoxadiazolePBPsStaphylococcus spp.

Identifiers

PMID29866865
PMCPMC6105842
OpenAlexW2807613774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.